These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17921033)

  • 1. Imaging multidrug resistance with 4-[18F]fluoropaclitaxel.
    Kurdziel KA; Kalen JD; Hirsch JI; Wilson JD; Agarwal R; Barrett D; Bear HD; McCumiskey JF
    Nucl Med Biol; 2007 Oct; 34(7):823-31. PubMed ID: 17921033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET imaging of multidrug resistance in tumors using 18F-fluoropaclitaxel.
    Kurdziel KA; Kiesewetter DO
    Curr Top Med Chem; 2010; 10(17):1792-8. PubMed ID: 20645913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human dosimetry and preliminary tumor distribution of 18F-fluoropaclitaxel in healthy volunteers and newly diagnosed breast cancer patients using PET/CT.
    Kurdziel KA; Kalen JD; Hirsch JI; Wilson JD; Bear HD; Logan J; McCumisky J; Moorman-Sykes K; Adler S; Choyke PL
    J Nucl Med; 2011 Sep; 52(9):1339-45. PubMed ID: 21849404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated synthesis of 18F analogue of paclitaxel (PAC): [18F]Paclitaxel (FPAC).
    Kalen JD; Hirsch JI; Kurdziel KA; Eckelman WC; Kiesewetter DO
    Appl Radiat Isot; 2007 Jun; 65(6):696-700. PubMed ID: 17161952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of paclitaxel biodistribution and uptake in human-derived xenografts in vivo with (18)F-fluoropaclitaxel.
    Gangloff A; Hsueh WA; Kesner AL; Kiesewetter DO; Pio BS; Pegram MD; Beryt M; Townsend A; Czernin J; Phelps ME; Silverman DH
    J Nucl Med; 2005 Nov; 46(11):1866-71. PubMed ID: 16269601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution, radiation dose estimates, and in vivo Pgp modulation studies of 18F-paclitaxel in nonhuman primates.
    Kurdziel KA; Kiesewetter DO; Carson RE; Eckelman WC; Herscovitch P
    J Nucl Med; 2003 Aug; 44(8):1330-9. PubMed ID: 12902425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive detection of multidrug resistance in patients with hematological malignancies: are we there yet?
    Kostakoglu L
    Clin Lymphoma; 2002 Mar; 2(4):242-8. PubMed ID: 11970764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting chemotherapy response to paclitaxel with 18F-Fluoropaclitaxel and PET.
    Hsueh WA; Kesner AL; Gangloff A; Pegram MD; Beryt M; Czernin J; Phelps ME; Silverman DH
    J Nucl Med; 2006 Dec; 47(12):1995-9. PubMed ID: 17138742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
    Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metalloprobes for functional monitoring of tumour multidrug resistance by nuclear imaging.
    Mendes F; Paulo A; Santos I
    Dalton Trans; 2011 May; 40(20):5377-93. PubMed ID: 21384018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrofosmin as predictors of tumour response.
    Fuster D; Viñolas N; Mallafré C; Pavia J; Martín F; Pons F
    Q J Nucl Med; 2003 Mar; 47(1):58-62. PubMed ID: 12714956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of (64)Cu(DO3A-xy-TPEP) as a potential PET radiotracer for monitoring tumor multidrug resistance.
    Liu S; Kim YS; Zhai S; Shi J; Hou G
    Bioconjug Chem; 2009 Apr; 20(4):790-8. PubMed ID: 19284752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 64Cu-labeled phosphonium cations as PET radiotracers for tumor imaging.
    Zhou Y; Liu S
    Bioconjug Chem; 2011 Aug; 22(8):1459-72. PubMed ID: 21696200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
    Sergieva SB; Timcheva KV; Hadjiolov ND
    J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study.
    Kurata S; Ushijima K; Kawahara A; Kaida H; Kawano K; Hirose Y; Kage M; Kamura T; Ishibashi M; Abe T
    Ann Nucl Med; 2015 Aug; 29(7):643-9. PubMed ID: 25921216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
    Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review.
    Liu FS
    Taiwan J Obstet Gynecol; 2009 Sep; 48(3):239-44. PubMed ID: 19797012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
    Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
    Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
    Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM
    Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.